Jim Simons
SLNO

Jim Simons’s Soleno Therapeutics SLNO Stock Holding History

Jim Simons’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15M Buy
+447,300
New +$17.5M 0.02% 770
2025
Q3 		– Sell
-45,200
Closed -$3.79M – 3868
2025
Q2 		$3.79M Buy
+45,200
New +$3.38M 0.01% 1695
2023
Q4 		– Sell
-61,554
Closed -$1.82M – 4095
2023
Q3 		$1.82M Sell
61,554
-4,500
-7% -$27.2K ﹤0.01% 1926
2023
Q2 		$283K Sell
66,054
-10,461
-14% -$45K ﹤0.01% 3154
2023
Q1 		$164K Buy
76,515
+26,761
+54% +$60.1K ﹤0.01% 3347
2022
Q4 		$99K Buy
49,754
+4,800
+11% +$5.97K ﹤0.01% 3621
2022
Q3 		$75K Buy
44,954
+8,279
+23% +$20.2K ﹤0.01% 3667
2022
Q2 		$102K Buy
36,675
+20,128
+122% +$55.7K ﹤0.01% 3849
2022
Q1 		$55K Buy
16,547
+12,507
+310% +$64.8K ﹤0.01% 3897
2021
Q4 		$25K Buy
4,040
+3,347
+483% +$35.1K ﹤0.01% 3834
2021
Q3 		$10K Sell
693
-24,253
-97% -$338K ﹤0.01% 3414
2021
Q2 		$427K Buy
+24,946
New +$421K ﹤0.01% 3023
2020
Q3 		– Sell
-9,617
Closed -$320K – 3656
2020
Q2 		$320K Buy
9,617
+1,853
+24% +$80.3K ﹤0.01% 3017
2020
Q1 		$277K Sell
7,764
-953
-11% -$40.5K ﹤0.01% 3007
2019
Q4 		$384K Sell
8,717
-1,708
-16% -$43.7K ﹤0.01% 2987
2019
Q3 		$235K Buy
10,425
+898
+9% +$28.6K ﹤0.01% 3099
2019
Q2 		$400K Buy
9,527
+5,285
+125% +$183K ﹤0.01% 3076
2019
Q1 		$131K Buy
+4,242
New +$113K ﹤0.01% 3271
2017
Q4 		– Sell
-354
Closed -$14K – 3488
2017
Q3 		$14K Buy
+354
New +$14K ﹤0.01% 3163

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Jim Simons's SLNO Position: Q1 2026 in Review

Jim Simons opened a new position in Soleno Therapeutics (SLNO) in Q1 2026: 447,300 shares worth $15M. The stake represents 0.02% of the portfolio and ranks #770 among its holdings. This is a return to the name: Jim Simons previously reported a position in SLNO as recently as Q2 2025.

Jim Simons first reported a position in SLNO in Q3 2017 and has held it in 19 quarters since. 225 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Jim Simons held 447,300 shares of Soleno Therapeutics worth $15M as of Q1 2026.
  • Soleno Therapeutics was a new Jim Simons position in Q1 2026.
  • Soleno Therapeutics made up 0.02% of Jim Simons's portfolio in Q1 2026, its #770 holding.
  • Jim Simons first reported a position in Soleno Therapeutics in Q3 2017 and has held it in 19 quarters since.
  • 225 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.